Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Innate Pharma S.A. Sponsored ADR (IPHA) had Receiveable Turnover of 0.73 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$10.19M |
|
$-55.64M |
|
-- |
|
$10.19M |
|
$71.29M |
|
$-61.11M |
|
$5.47M |
|
$-55.64M |
|
$-55.64M |
|
$-55.64M |
|
$-55.64M |
|
$-55.64M |
|
$-55.64M |
|
$-61.11M |
|
$-59.54M |
|
89.59M |
|
89.59M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$52.85M |
|
$4.93M |
|
$18.11M |
|
$70.96M |
|
$41.46M |
|
$15.58M |
|
$54.05M |
|
$95.52M |
|
$-24.56M |
|
$-24.56M |
|
$-24.56M |
|
83.84M |
|
| Cash Flow Statement Financials | |
$-59.69M |
|
$8.25M |
|
$6.87M |
|
$75.12M |
|
$31.78M |
|
$-43.34M |
|
$2.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
-1.74 |
|
-1.04 |
|
100.00% |
|
-599.77% |
|
-599.77% |
|
-584.40% |
|
-546.11% |
|
-546.11% |
|
$-59.85M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
|
Receiveable Turnover |
0.73 |
502.61 |
|
226.58% |
|
226.58% |
|
-78.41% |
|
619.90% |
|
$-0.29 |
|
$-0.67 |
|
$-0.67 |
|